Raymond James & Associates cut its stake in Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 56.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 250,052 shares of the business services provider's stock after selling 329,208 shares during the period. Raymond James & Associates owned about 0.27% of Stericycle worth $15,253,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Capital Research Global Investors increased its position in Stericycle by 11.4% during the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider's stock valued at $351,732,000 after buying an additional 679,974 shares in the last quarter. Earnest Partners LLC lifted its position in shares of Stericycle by 12.4% in the first quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider's stock valued at $129,766,000 after acquiring an additional 271,025 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Stericycle by 7.0% during the second quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider's stock worth $126,238,000 after buying an additional 142,814 shares in the last quarter. Pentwater Capital Management LP purchased a new position in Stericycle during the second quarter worth about $83,010,000. Finally, Magnetar Financial LLC purchased a new position in shares of Stericycle during the second quarter worth $81,596,000. Institutional investors own 98.82% of the company's stock.
Stericycle Price Performance
Shares of NASDAQ:SRCL traded up $0.04 during trading hours on Friday, hitting $60.91. 468,526 shares of the company's stock traded hands, compared to its average volume of 1,120,243. Stericycle, Inc. has a 52 week low of $37.78 and a 52 week high of $61.77. The company's fifty day simple moving average is $60.56 and its two-hundred day simple moving average is $56.39. The company has a market cap of $5.65 billion, a price-to-earnings ratio of -276.86, a price-to-earnings-growth ratio of 3.33 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13.
Stericycle (NASDAQ:SRCL - Get Free Report) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The company had revenue of $661.60 million during the quarter, compared to the consensus estimate of $672.07 million. As a group, equities analysts anticipate that Stericycle, Inc. will post 2.29 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on Stericycle in a research report on Sunday. They issued a "hold" rating for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $74.00.
Check Out Our Latest Analysis on SRCL
Stericycle Profile
(
Free Report)
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Read More
Before you consider Stericycle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.
While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.